Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 01, 2021 17:16 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Announces Closing of $10.0 Million Private Placement Priced At-the-Market

RUTHERFORD, N.J., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today...
January 07, 2021 16:05 ET | Source: Cancer Genetics, Inc.

Cancer Genetics to Present at the 2021 BioConnect Virtual Conference Hosted by H.C. Wainwright

RUTHERFORD, N.J., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), an emerging leader in novel drug discovery techniques, announced today that Jay Roberts,...
November 12, 2020 12:25 ET | Source: Moore Kuehn

Moore Kuehn Encourages CGIX, CXO, CBMG, and RESI Investors to Contact Law Firm

NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether...
October 19, 2020 15:24 ET | Source: Rigrodsky & Long, P.A.

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of EIDX, ARA, MVC, and CGIX Mergers

WILMINGTON, Del., Oct. 19, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Eidos Therapeutics, Inc. (NASDAQ GS: EIDX) regarding possible breaches of...
October 14, 2020 13:14 ET | Source: Rigrodsky & Long, P.A.

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of EIDX, VRTU, CBMG, and CGIX Mergers

WILMINGTON, Del., Oct. 14, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Eidos Therapeutics, Inc. (NASDAQ GS: EIDX) regarding possible breaches of...
September 23, 2020 15:00 ET | Source: Rigrodsky & Long, P.A.

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of AIMT, BMCH, BYFC, and CGIX Mergers

WILMINGTON, Del., Sept. 23, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: Aimmune Therapeutics, Inc. (NASDAQ GS: AIMT) regarding possible breaches of...
September 18, 2020 06:18 ET | Source: Research and Markets

The Global Viral Vector & Plasmid DNA Manufacturing Market to Grow USD 2,101.82 Million by 2025, at a CAGR of 24.97%

Dublin, Sept. 18, 2020 (GLOBE NEWSWIRE) -- The "Viral Vector & Plasmid DNA Manufacturing Market Research Report by Type, by Application, by End User - Global Forecast to 2025 - Cumulative Impact...
September 02, 2020 20:00 ET | Source: Rigrodsky & Long, P.A.

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of BMCH, BYFC, CGIX, and PTI Mergers

WILMINGTON, Del., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating: BMC Stock Holdings, Inc. (NASDAQ GS: BMCH) regarding possible breaches of...
June 24, 2020 17:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Reports First Quarter 2020 Financial Results and Provides Strategic Business Updates

RUTHERFORD, N.J., June 24, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today...
November 20, 2019 08:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Reports Third Quarter 2019 Financial Results and Provides Strategic Business Update

RUTHERFORD, N.J., Nov. 20, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced strategic,...